Magnetic pulses to the brain may offer rapid relief from prolonged grief
NCT ID NCT06953596
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This trial tests whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can safely and feasibly treat prolonged grief disorder. Fifteen bereaved adults with high grief scores will receive eight sessions of rTMS daily for five days, targeting a brain region linked to mood. The goal is to see if this approach is tolerable and promising enough to study further as a faster alternative to therapy or medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Repetitive transcranial magnetic stimulation (rTMS)
- What this could lead to
- If it works, this could point toward a fast, non-drug treatment for prolonged grief disorder, a condition that currently has limited options.
- What could go wrong
- This is a very early, small study with only 15 people and no placebo group, so results may not apply broadly. The treatment is experimental for this condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLICATED GRIEF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bruyere Health
RECRUITINGOttawa, Ontario, K1R 7A5, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.